PLAUR+ Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment
This story is reported by Wiley & Sons. Read what other outlets are saying below, then open the original report for full details.